An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens

Needle core biopsy (NCB), as part of triple assessment for preoperative evaluation and diagnosis of breast cancer, is now considered as an established, highly accurate method for diagnosing breast cancer that has replaced either fine needle aspiration cytology or excisional biopsy as the initial diagnostic biopsy procedures in many institutions. In addition to its primary role in establishing an accurate histological diagnosis, NCB can potentially provide important additional pathological prognostic information which may be of direct clinical value in certain situations, such as patients being considered for preoperative (neoadjuvant) therapy. With this background in mind we briefly review the current role of NCB in breast cancer diagnosis and then concentrate this review on the usefulness and issues relating to use of this technique in providing accurate, reliable and clinically relevant preoperative prognostic and predictive information in patients with breast cancer.

[1]  M. Gnant,et al.  Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer , 2004, Wiener Klinische Wochenschrift.

[2]  F. Dalenc.  [Breast cancers]. , 2008, Revue de l'infirmiere.

[3]  D. Dabbs,et al.  Predictors of Residual Invasive Disease after Core Needle Biopsy Diagnosis of Ductal Carcinoma In Situ , 2007, The breast journal.

[4]  C. Balu-Maestro,et al.  Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology. , 2007, Clinical imaging.

[5]  H. Sasano,et al.  Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. , 2007, Japanese journal of clinical oncology.

[6]  S. Ciatto,et al.  Underestimation of malignancy of breast core‐needle biopsy , 2007, Cancer.

[7]  K Fenwick,et al.  Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy , 2006, British Journal of Cancer.

[8]  I. Ellis,et al.  The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast , 2006, Journal of Clinical Pathology.

[9]  P. Michenet,et al.  Place des macrobiopsies mammaires assistées par le vide sous guidage échographique: étude multi-centrique de 650 lésions , 2008 .

[10]  N. Sneige,et al.  Predictors of invasion in patients with core‐needle biopsy‐diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ , 2006, Cancer.

[11]  C. Tourasse,et al.  [Value of vacuum assisted biopsies under sonography guidance: results from a multicentric study of 650 lesions]. , 2006, Journal de radiologie.

[12]  M. Dillon,et al.  Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice , 2006, Journal of Clinical Pathology.

[13]  S. Apple,et al.  Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? , 2006, Breast.

[14]  T. Karn,et al.  Gene Expression Profiles of Breast Cancer Obtained from Core Cut Biopsies Before Neoadjuvant Docetaxel, Adriamycin, and Cyclophoshamide Chemotherapy Correlate with Routine Prognostic Markers and Could Be Used to Identify Predictive Signatures , 2005, Zentralblatt fur Gynakologie.

[15]  L. Newman,et al.  Does the Method of Biopsy Affect the Incidence of Sentinel Lymph Node Metastases? , 2006, The breast journal.

[16]  F. Akiyama,et al.  Present state of and problems with core needle biopsy for non-palpable breast lesions , 2006, Breast cancer.

[17]  R. Cahill,et al.  Preoperative Profiling of Symptomatic Breast Cancer by Diagnostic Core Biopsy , 2006, Annals of Surgical Oncology.

[18]  L. Hirsch.  Competing interests: none declared. , 2006 .

[19]  Niall O'Higgins,et al.  The Accuracy of Ultrasound, Stereotactic, and Clinical Core Biopsies in the Diagnosis of Breast Cancer, With an Analysis of False-Negative Cases , 2005, Annals of surgery.

[20]  S. Harms,et al.  Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. , 2005, American journal of surgery.

[21]  K. Mokbel,et al.  Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? , 2005, International Seminars in Surgical Oncology.

[22]  M. Buchanan,et al.  Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Kyung Soo Cho,et al.  Sonographically Guided Core Biopsy of the Breast: Comparison of 14-Gauge Automated Gun and 11-Gauge Directional Vacuum-Assisted Biopsy Methods , 2005, Korean journal of radiology.

[24]  S. Singletary,et al.  Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. , 2005, Journal of the American College of Surgeons.

[25]  E. Mittendorf,et al.  Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. , 2005, Current surgery.

[26]  K. Griffith,et al.  Pathologic Features of Breast Cancer Associated With Complete Response to Neoadjuvant Chemotherapy: Importance of Tumor Necrosis , 2005, The American journal of surgical pathology.

[27]  A. Maruani,et al.  Pathological prognostic factors of invasive breast carcinoma in ultrasound-guided large core biopsies-correlation with subsequent surgical excisions. , 2005, Breast.

[28]  A. Cavaliere,et al.  Biopathologic profile of breast cancer core biopsy: is it always a valid method? , 2005, Cancer letters.

[29]  S. Holt,et al.  Core biopsy as a tool in planning the management of invasive breast cancer , 2005, World journal of surgical oncology.

[30]  D. Monticciolo.  Histologic Grading at Breast Core Needle Biopsy: Comparison with Results from the Excised Breast Specimen , 2005, The breast journal.

[31]  H. Sasano,et al.  Pathological aspects of core needle biopsy for non-palpable breast lesions , 2005, Breast cancer.

[32]  C. Gomez-Fernandez,et al.  Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers. , 2005, American journal of clinical pathology.

[33]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[34]  H. Gobbi,et al.  Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen , 2004, Virchows Archiv.

[35]  L. Kaufman,et al.  Stereotactic core breast biopsy of malignant calcifications: diagnostic yield of cores with and cores without calcifications on specimen radiographs. , 2004, Radiology.

[36]  A. Renshaw.  Minimal (< or =0.1 cm) invasive carcinoma in breast core needle biopsies. Incidence, sampling, associated findings, and follow-up. , 2004, Archives of pathology & laboratory medicine.

[37]  I. Ellis,et al.  Best Practice No 179 , 2004, Journal of Clinical Pathology.

[38]  R. Plantade,et al.  Sous-estimation du cancer du sein par les macrobiopsies stereotaxiques 11-gauge , 2004 .

[39]  B. McNeil,et al.  Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. , 2004, Academic radiology.

[40]  A. Hanby,et al.  Agreement between preoperative core needle biopsy and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained , 2004, Journal of Clinical Pathology.

[41]  H. Verkooijen,et al.  Stereotactic Large Core Needle Biopsy for All Nonpalpable Breast Lesions? , 2002, Breast Cancer Research and Treatment.

[42]  I. Ellis,et al.  Guidelines for breast needle core biopsy handling and reporting in breast screening assessment , 2004 .

[43]  J. Pastorek,et al.  Semi-quantitative RT-PCR assessment of molecular markers in breast large-core needle biopsies. , 2004, Neoplasma.

[44]  L. Rydén,et al.  Assessment of microvessel density in core needle biopsy specimen in breast cancer. , 2004, Anticancer research.

[45]  J. Hammou,et al.  [Underestimation of breast carcinoma with 11-gauge stereotactically guided directional vacuum-assisted biopsy]. , 2004, Journal de radiologie.

[46]  S. Ciatto,et al.  Florence–Sydney Breast Biopsy Study: sensitivity of ultrasound-guided versus freehand fine needle biopsy of palpable breast cancer , 2004, Breast Cancer Research and Treatment.

[47]  T. Hwang,et al.  Intraoperative Ultrasonographically Guided Excisional Biopsy or Vacuum-Assisted Core Needle Biopsy for Nonpalpable Breast Lesions , 2003, Annals of surgery.

[48]  R. Anand,et al.  A Prospective Study of the Use of Fine‐Needle Aspiration Cytology and Core Biopsy in the Diagnosis of Breast Cancer , 2003, The breast journal.

[49]  R Holland,et al.  Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesions. , 2003, European journal of cancer.

[50]  S. Pinder,et al.  Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer , 2003, British Journal of Cancer.

[51]  K. Mokbel.  Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects. , 2003, International journal of fertility and women's medicine.

[52]  Wong Te,et al.  Core needle biopsy of palpable breast lump: the influence of needle size. , 2003 .

[53]  I. Ellis,et al.  Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma , 2003, The American journal of surgical pathology.

[54]  T. Wong,et al.  Core needle biopsy of palpable breast lump: the influence of needle size. , 2003, The Medical journal of Malaysia.

[55]  I. B. Borel Rinkes,et al.  The Finding of Invasive Cancer After a Preoperative Diagnosis of Ductal Carcinoma-In-Situ: Causes of Ductal Carcinoma-In-Situ Underestimates With Stereotactic 14-Gauge Needle Biopsy , 2003, Annals of Surgical Oncology.

[56]  A. Hutcheon,et al.  Freehand core biopsy in breast cancer: an accurate predictor of tumour grade following neoadjuvant chemotherapy? , 2002, Breast.

[57]  M. Mayo,et al.  A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. , 2002, American journal of surgery.

[58]  D. Wallwiener,et al.  Large-core needle biopsy for diagnosis and treatment of breast lesions , 2002, Archives of Gynecology and Obstetrics.

[59]  H. Verkooijen.  Diagnostic accuracy of stereotactic large‐core needle biopsy for nonpalpable breast disease: Results of a multicenter prospective study with 95% surgical confirmation , 2002, International journal of cancer.

[60]  D. Visscher,et al.  Histologic and Radiographic Analysis of Ductal Carcinoma In Situ Diagnosed Using Stereotactic Incisional Core Breast Biopsy , 2002, Modern Pathology.

[61]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[62]  G. Sterrett,et al.  Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis , 2002, Pathology.

[63]  Andrew A Renshaw,et al.  Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. , 2002, Archives of pathology & laboratory medicine.

[64]  G. Heinze,et al.  Prognostic relevance of three histological grading methods in breast cancer. , 2001, International journal of oncology.

[65]  I. Ellis,et al.  Predicting invasion in mammographically detected microcalcification. , 2001, Clinical radiology.

[66]  N. Dallimore,et al.  Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? , 2001, Journal of clinical pathology.

[67]  G. Farr,et al.  A Mass on Breast Imaging Predicts Coexisting Invasive Carcinoma in Patients with a Core Biopsy Diagnosis of Ductal Carcinoma in Situ , 2001, The American surgeon.

[68]  D. Page,et al.  Core Biopsy of the Breast With Atypical Ductal Hyperplasia: A Probabilistic Approach to Reporting , 2001, The American journal of surgical pathology.

[69]  A. Renshaw,et al.  Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. , 2001, American journal of clinical pathology.

[70]  Rex C. Bentley,et al.  Impact of Core-Needle Breast Biopsy on the Surgical Management of Mammographic Abnormalities , 2001, Annals of surgery.

[71]  S. Goodman,et al.  Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices. , 2001, Radiology.

[72]  M. Briley,et al.  The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions , 2001, Journal of clinical pathology.

[73]  M. Sentís,et al.  Ductal Carcinoma In Situ and Atypical Ductal Hyperplasia of the Breast Diagnosed at Stereotactic Core Biopsy , 2001, The breast journal.

[74]  I. Ellis,et al.  Preoperative assessment of prognostic factors in breast cancer , 2001, Journal of clinical pathology.

[75]  I. Ellis,et al.  Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. , 1999, European journal of cancer.

[76]  K. Mai,et al.  Predictive value of extent and grade of ductal carcinoma in situ in radiologically guided core biopsy for the status of margins in lumpectomy specimens. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[77]  C. Lee,et al.  Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? , 2000, Radiology.

[78]  N. Horeczko,et al.  Menses and breast cancer: Does timing of mammographically directed core biopsy affect outcome? , 2000, Journal of Surgical Oncology.

[79]  I. Ellis,et al.  When have mammographic calcifications been adequately sampled at needle core biopsy? , 2000, Clinical radiology.

[80]  D. Winchester,et al.  The diagnosis and management of ductal carcinoma in‐situ of the breast , 2000, CA: a cancer journal for clinicians.

[81]  D. Barnes,et al.  Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems , 2000, Journal of clinical pathology.

[82]  H. Verkooijen,et al.  Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis , 2000, British Journal of Cancer.

[83]  S. Schnitt,et al.  Assessment of pathologic prognostic factors in breast core needle biopsies. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[84]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[85]  R. Wait,et al.  Accurate Prediction of the Amount of In Situ Tumor in Palpable Breast Cancers by Core Needle Biopsy: Implications for Neoadjuvant Therapy , 1999, Annals of Surgical Oncology.

[86]  M. Lagios.  An Expanded Diagnostic Role for Core Biopsy: Assessment of the Proportion of the Duct Carcinoma In Situ Component in Invasive Carcinomas , 1999, Annals of Surgical Oncology.

[87]  M. Sikka,et al.  Interobserver agreement of the Nottingham histologic grading scheme for infiltrating duct carcinoma breast. , 1999, Indian journal of cancer.

[88]  C. Lee,et al.  Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. , 1999, AJR. American journal of roentgenology.

[89]  S. Pinder,et al.  The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy , 1998, Cancer.

[90]  M. Gnant,et al.  [Value of punch biopsy in diagnosis of palpable breast tumors. A prospective analysis of 150 patients]. , 1998, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[91]  R. Jakesz,et al.  Die Wertigkeit der Stanzbiopsie in der Diagnostik palpabler Brusttumoren Eine prospektive Analyse von 150 Patienten , 1998, Der Chirurg.

[92]  I. Ellis,et al.  An audit of grading and typing of invasive breast carcinoma on needlecore biopsy specimens , 1998 .

[93]  S. Schnitt,et al.  Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[94]  W. P. Evans,et al.  Stereotactic Core‐Needle Biopsy of the Breast: A Report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists , 1997, CA: a cancer journal for clinicians.

[95]  R. Warren,et al.  Changing to core biopsy in an NHS breast screening unit. , 1997, Clinical radiology.

[96]  B. Muir,et al.  The impact of core-biopsy on pre-operative diagnosis rate of screen-detected breast cancers. , 1997, Clinical Radiology.

[97]  I. B. Borel Rinkes,et al.  The diagnostic accuracy of core biopsy in palpable and non-palpable breast lesions. , 1997, European journal of radiology.

[98]  S. Shousha,et al.  Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. , 1997, Journal of clinical pathology.

[99]  C. Zuiani,et al.  Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas. , 1996, European journal of cancer.

[100]  R. Parsons,et al.  Stereotactic 14 gauge core-biopsy of the breast: results from 101 patients. , 1996, The Australian and New Zealand journal of surgery.

[101]  I. Ellis,et al.  The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers. , 1996, Clinical radiology.

[102]  J. Dahlstrom,et al.  Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions , 1996, Histopathology.

[103]  J. Norton,et al.  Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. , 1996, Annals of surgery.

[104]  S. Pinder,et al.  The role of pre‐operative diagnosis in breast cancer , 1996, Histopathology.

[105]  J. Dahlstrom,et al.  Diagnostic accuracy of stereotactic core biopsy in a mammographic breast cancer screening programme , 1996, Histopathology.

[106]  R. Place,et al.  Stereotactic breast biopsy is accurate, minimally invasive, and cost effective. , 1996, American journal of surgery.

[107]  D. Schultz,et al.  Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[108]  W. P. Evans,et al.  Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. , 1996, AJR. American journal of roentgenology.

[109]  M J Gaffey,et al.  Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. , 1995, American journal of clinical pathology.

[110]  P. Israel,et al.  Stereotactic needle biopsy for occult breast lesions: a minimally invasive alternative. , 1995, The American surgeon.

[111]  G. W. Eklund,et al.  Percutaneous large-core breast biopsy: a multi-institutional study. , 1994, Radiology.

[112]  R. J. Jackman,et al.  Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. , 1994, Radiology.

[113]  L. Liberman,et al.  Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed? , 1994, Radiology.

[114]  W D Dupont,et al.  Histologic grading of breast carcinoma. A reproducibility study , 1994, Cancer.

[115]  S. Pinder,et al.  Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up , 1994, Histopathology.

[116]  R. Blamey,et al.  Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐up , 1992, Histopathology.

[117]  J. Pain,et al.  Assessment of breast cancer size: a comparison of methods. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[118]  P. Jokich,et al.  Nonpalpable breast lesions: findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology. , 1991, Radiology.

[119]  A. Howell,et al.  Extended role for needle biopsy in the management of carcinoma of the breast , 1989, The British journal of surgery.

[120]  S. Feig,et al.  Heterogeneity of intraductai carcinoma of the breast , 1989 .

[121]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .

[122]  S. Feig,et al.  Heterogeneity of intraductal carcinoma of the breast. , 1989, Cancer.

[123]  R. Blamey,et al.  A prognostic index in primary breast cancer. , 1982, British Journal of Cancer.

[124]  J. Bolmgren,et al.  Stereotaxic instrument for needle biopsy of the mamma. , 1977, AJR. American journal of roentgenology.

[125]  N. Delarue.  Primary breast cancer. , 1969, Canadian family physician Medecin de famille canadien.